Literature DB >> 4068359

Carcinoembryonic antigen in bronchoalveolar lavage fluid in patients with idiopathic pulmonary fibrosis.

H Takahashi, T Nukiwa, R Matsuoka, T Danbara, H Natori, T Arai, S Kira.   

Abstract

An increased incidence of lung cancer and epithelial metaplasia or hyperplasia which is felt to be as a precursor of cancer, has been reported in patients with idiopathic pulmonary fibrosis (IPF). In this study, carcinoembryonic antigen (CEA) in bronchoalveolar lavage (BAL) fluid was measured in 53 control patients, 31 patients with sarcoidosis, 10 patients with hypersensitivity pneumonitis, 16 patients with primary lung cancer and 26 patients with histologically confirmed IPF. High ratio of CEA to albumin (Alb), exceeding mean + 2SD of nonsmoking control patients, were found in 8 (25%) out of 32 smoking control patients, 4 (44%) out of 9 nonsmoking patients with IPF, 8 (62%) out of 13 smoking patients with IPF, 3 (75%) out of 4 smoking patients with IPF and lung cancer and 13 (81%) out of 16 patients with primary lung cancer, although BAL was performed at the noncancerous parts of the lung in the cases of lung cancer. Furthermore, it was confirmed that CEA increased in BAL fluid in these subjects were different from nonspecific cross-reacting antigen (NCA) which was detectable in the normal lung. Thus we consider that the increase of CEA/Alb ratio in BAL fluid is a possible marker of these early histological disorders in the lung, and also suggests a greater risk of malignant change in the clinical course of IPF.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4068359     DOI: 10.2169/internalmedicine1962.24.236

Source DB:  PubMed          Journal:  Jpn J Med        ISSN: 0021-5120


  8 in total

Review 1.  Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis.

Authors:  P L Shah; D Hansell; P R Lawson; K B Reid; C Morgan
Journal:  Thorax       Date:  2000-01       Impact factor: 9.139

2.  Serum sialyl Lewis X-i antigen in lung adenocarcinoma and idiopathic pulmonary fibrosis.

Authors:  H Satoh; H Ishikawa; Y T Yamashita; M Ohtsuka; K Sekizawa
Journal:  Thorax       Date:  2002-03       Impact factor: 9.139

3.  Tumor markers are associated with rapidly progressive interstitial lung disease in adult-dermatomyositis.

Authors:  Qianqian Wang; Congcong Gao; Chunyi Zhang; Menghui Yao; Wenfang Liang; Wenbo Sun; Zhaohui Zheng
Journal:  Clin Rheumatol       Date:  2022-02-09       Impact factor: 2.980

4.  A Case of Radiation Fibrosis Appearing as Mass-Like Consolidation after SBRT with Elevation of Serum CEA.

Authors:  Kotaro Terashima; Yoshiyuki Shioyama; Satoshi Nomoto; Saiji Ohga; Takeshi Nonoshita; Kayoko Ohnishi; Kazushige Atsumi; Hidetake Yabuuchi; Hideki Hirata; Hiroshi Honda
Journal:  Case Rep Med       Date:  2010-06-06

5.  The relationship between the severity of pulmonary fibrosis and the lung cancer stage.

Authors:  Hye Jin Jang; Moo Suk Park; Young Sam Kim; Joon Chang; Jae Ho Lee; Choon-Taek Lee; Sang Hoon Lee; Ho Il Yoon
Journal:  J Cancer       Date:  2021-03-14       Impact factor: 4.207

6.  Value of Serum Carbohydrate Antigen 19-9 and Carcinoembryonic Antigen in Evaluating Severity and Prognosis of Connective Tissue Disease-Associated Interstitial Lung Disease.

Authors:  Qian Jin; Jisheng Zheng; Xianrong Xu; Yeming Hu; Ying Zhou; Weihua Xu; Feihua Huang
Journal:  Arch Rheumatol       Date:  2017-10-16       Impact factor: 1.472

7.  Lung cancer and interstitial lung diseases: a systematic review.

Authors:  Kostas Archontogeorgis; Paschalis Steiropoulos; Argyris Tzouvelekis; Evangelia Nena; Demosthenes Bouros
Journal:  Pulm Med       Date:  2012-07-29

8.  Nonspecific crossreacting antigen (NCA) is a major member of the carcinoembryonic antigen (CEA)-related gene family expressed in lung cancer.

Authors:  T Hasegawa; K Isobe; Y Tsuchiya; S Oikawa; H Nakazato; I Nakashima; K Shimokata
Journal:  Br J Cancer       Date:  1993-01       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.